ArticleFrontiers in surgery2026
Strategic application of multilayer fat grafting in facial rejuvenation: a retrospective study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing fat graft survival: from adipose-derived stem cell mechanisms to next-generation regenerative strategies.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Backgrounds: Facial aging is characterized by complex volumetric changes involving soft tissue atrophy and skeletal remodeling. Autologous fat grafting has evolved as a primary technique, though unpredictable graft retention remains a challenge. Objective: The study aims to provide the strategic application of differentially processed adipose products by matching material properties to anatomical requirements. Methods: This retrospective study analyzed 105 patients undergoing facial fat grafting for age-related contour deformities. Adipose products, including high-density fat (HDF), adipose matrix complex (AMC), and stromal vascular fraction gel (SVF-gel), were injected into specific anatomical layers. Outcome assessments included clinical evaluation and standardized photographic documentation, Visual Analog scale, and Global Aesthetic Improvement Scale. Results: All patients achieved significant aesthetic improvement with no major complications. Early side effects resolved spontaneously within 3 weeks. Sixteen patients required secondary procedures due to partial volume absorption. SVF-gel demonstrated efficacy in periorbital rejuvenation and skin quality enhancement, while HDF and AMC provided stable structural support in deeper facial regions. Patient-reported satisfaction scores were 5.26 ± 1.84 preoperatively and 8.01 ± 1.09 postoperatively. Observer assessments using the Global Aesthetic Improvement Scale (GAIS, -1 to 3) yielded a postoperative score of 1.88 ± 0.65. Conclusions: The targeted application of processed adipose products based on their biological properties and recipient site requirements enables effective, multilayer facial restoration. This approach addresses both volumetric deficits and skin quality concerns, offering a comprehensive solution for facial rejuvenation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.